Refractory psoriasis vulgaris with itching successfully treated with the anti-interleukin-17A antibody secukinumab: A case of secondary failure of other biologic agents
Saved in:
Main Authors: | Yuko Kurosaki (Author), Kenji Takamori (Author), Yasushi Suga (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab
by: Anna Schuch, et al.
Published: (2017) -
Secukinumab - first in class interleukin-17A inhibitor for the treatment of psoriasis
by: Kiran Godse
Published: (2017) -
Promising results with secukinumab in refractory pediatric psoriasis
by: Sukriti Baveja, et al.
Published: (2020) -
Interleukin-17A Inhibitor Secukinumab Treatment in HIV-Positive Psoriasis Patient: A Case Report
by: Gong J, et al.
Published: (2022) -
A Review of the Safety of Interleukin-17A Inhibitor Secukinumab
by: Vishnu Eshwar, et al.
Published: (2022)